Mankind Pharma543904Pharmaceuticals
Srikanth Chauhan of Kotak Securities recommended buying Mankind Pharma with a technical target of 2,900-3,000 rupees
- Stock move today
- 4 percent
- Technical target
- 2,900 to 3,000 rupees
Heard on Live TV News Channel between 13:37:35 - 13:38:50 IST.
- Srikanth Chauhan said Mankind Pharma is up 4% today and has crossed previous highs after consolidating for weeks.
- He said the stock is a buy even at current levels based on its technical formation.
- He set a target of at least 2,900, possibly 3,000 rupees.
Also from Mankind Pharma
Analyst recommended buying Mankind Pharma citing long buildup in derivatives and breakout above resistance
29 Sep 2026
Statutory Auditors Resign at Material Wholly Owned Subsidiary Following Voluntary Liquidation Start
28 Sep 2026
Source: Live TV News Channel · 29 Sep 2026
The call above is Srikanth Chauhan, Kotak Securities's, reported here as they made it. Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.